| Document Date: 2014-07-01 15:56:02
Open Document File Size: 287,88 KBShare Result on Facebook
Company BP / Astellas Pharma US Inc. / Alteon Inc. / / Country Japan / / Event FDA Phase / / IndustryTerm food consumption / chemical / food / / MedicalCondition glaucoma / purpura / overactive bladder / Neoplasms / baseline hypertension / hypertension / vulvovaginal pruritus / lung neoplasm / headache / neoplasm / Skin disorders / Urinary Retention / urinary disorders / nasopharyngitis / Eye Disorders / Carcinogenesis / urinary tract infection / subcutaneous tissue disorders / ESRD / cerebrovascular accident / Bladder Outlet Obstruction / nausea / urge urinary incontinence / cardiomegaly / Stevens-Johnson syndrome / increased urinary retention / severe uncontrolled hypertension / osteoarthritis / pain / leukocytoclastic vasculitis / urticaria / abdominal distension Infections / gastritis / Cardiac disorders / fetal death / tachycardia / diarrhea / malignant and prostate cancer / Atrial fibrillation / End Stage Renal Disease / sinusitis / dizziness / prostate cancer / constipation / pruritus / OAB Urinary retention / rash / breast cancer / nephrolithiasis / breast disorders / Patients With Bladder Outlet Obstruction / / MedicalTreatment oral contraceptives / hemodialysis / / Organization US Federal Reserve / DOSAGE AND ADMINISTRATION / FDA / / / Position physician / Major / / Product Digoxin / tamsulosin / polyethylene glycol / ketoconazole / BP / dimethyl sulfoxide / beta-2 / rifampin / Myrbetriq / / ProvinceOrState Arkansas / / Technology alpha / Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
Microsoft Word - 13C011-MIR-WPI.doc